Ann: December 2020 Quarterly Update and Appendix 4C, page-16

It's the external collaboration potential that makes Omni Car so exciting.

The likes of Johnson and Johnson are sitting on a very valuable CAR-T drug, but it's plagued with issues. Omni Car appears to offer a solution to all of the issues - and it's created by those who developed CAR-T in the first place.

So the likes of Johnson and Johnson have already invested billions and worked on their program lots. What's 500m more to get it working perfectly?

Hence Omni Car could soon be doing phase 2 or 3 trials, enhancing current therapies.